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We live in a scientific universe in
which subject boundaries are increas-
ingly porous. Department definitions
in many institutions are either close to
meaningless or nonexistent, and many
faculty count themselves as active par-
ticipants in at least two, if not more, of
the major disciplines of biology. Thus, it
is with great pleasure that we announce
a new cross-listing project for the 
 
JEM
 
and the 
 
JCB
 
.
An increasing number of papers in
the two journals include subject matter
vital to both immunologists and cell
biologists. For these papers, we will
include a listing not only on the table
of contents of the hosting journal, but
also on the online table of contents of
the sister journal (both the 
 
JEM
 
 and
 
JCB
 
 are published by the Rockefeller
University Press). 
 
JEM
 
 subscribers will
get free access to the listed 
 
JCB
 
 articles
and vice versa. The relevant papers
will be identified by the editors, often
on the recommendations of our review-
ers or submitting authors. This arrange-
ment addresses the need to bring to-
gether the fields of cell biology,
immunology, human disease, and mi-
crobial pathogenesis.
Based on our subscription lists, the
 
JEM
 
 and 
 
JCB
 
 readerships do not over-
lap much. Thus, the cross-listing will
give extra exposure to papers at the
interface between these subject areas,
and make these papers accessible to
readers who might otherwise not have
seen a given paper, were it to have
appeared in only one journal. Basic
mechanisms of cellular motility and
organization will be brought to the
attention of those studying immune
activation, immune cell interactions
will be highlighted for those studying
signaling, and a wide array of patho-
gens and human disease states will be
featured as potential models for cell
biology investigation.
The 
 
JCB
 
 and 
 
JEM
 
 are both leading
journals in their fields, and immunol-
ogy and cell biology represent two of
the biggest fields in terms of the num-
ber of papers and journals published.
Readers are struggling just to keep up
with what is published in the top tier
journals in their own field. We hope
to do some of the work for these readers
by alerting them to relevant content in
another leading journal—a journal
that they might not have time to scan
in its entirety.
By cross-listing relevant content, we
feel we will enhance the cause of com-
munication between scientific commu-
nities that do not interact nearly as
much as they should. Further, by in-
creasing the visibility of papers at the
interface of experimental medicine and
cell biology, both the 
 
JCB
 
 and the
 
JEM
 
—not-for-profit journals edited by
your colleagues and whose contents are
available free online 6 months after
publication—will become even more
attractive choices for submitting your
best work. Let the collaborations begin!
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